Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Healthcare Realty Trust (HR) · oqro.io/stocks/HR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Questions about Healthcare Realty Trust insider trading
Have Healthcare Realty Trust insiders bought shares recently?
No open-market purchase by an insider of Healthcare Realty Trust was filed in the last 90 days. The latest on record was on Mar 6, 2026.
How often do Healthcare Realty Trust insiders buy and sell shares?
Since 2012, Healthcare Realty Trust insiders reported 70 open-market purchases and 21 sales on Forms 4 and 5, with purchases in 13 different years, most recently 2026.
Who is selling Healthcare Realty Trust stock?
In the last 90 days, 1 insider of Healthcare Realty Trust (HR) reported 1 open-market sale worth $401K in total on SEC Form 4. The largest seller by value was Robert E Hull, with $401K. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Do members of Congress trade HR?
No trade in Healthcare Realty Trust (HR) was disclosed by a member of Congress in the last 12 months.
When does Healthcare Realty Trust report its next results?
Healthcare Realty Trust's next results are expected on Feb 10, 2027, before the market opens. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+10.6% (+$1.85) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $17.51 on Nov 20, 2025 to $19.36 on Nov 20, 2026 (+10.6%). Disclosed in this range: 4 insider trades, 0 pre-arranged insider sales, 0 Congress trades, and 16 13F position changes for 3 quarters ending in it.
2 insiders bought
$14$16$18$22$24$19.36
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 4 trades in this range as a list
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care REITs company.
Last 12 months
+10.6%
S&P 500 +5.7% over the same dates
Market value
$6.55B
Close of Nov 20, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 17M shares sold short (5.0% of shares outstanding), −3.0% vs the previous count, 2.6 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
8 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 7, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Since Nov 19, 2025, HR is up 8.3% and the index fund is up 4.1%: 4 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much HR moves
A usual day
±0.7%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
2.0%How far the price usually travels in a session, the gap from the day before included. Wilder's 14-session average.
Largest one-day fall
−4.1%Mar 20, 2026
Largest one-day rise
+4.2%Jun 9, 2026
Deepest fall of the year
−22.8%From the close of Jul 28, 2026 to Oct 7, 2026.
Days of 5% or more
0Out of 252 sessions, in either direction.
Beta 0.1(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Insider buying and selling since 2012
Insiders of Healthcare Realty Trust reported 70 open-market purchases and 21 sales since 2012; purchases in 13 different years, most recently 2026.
Year
Bought
Sold
2026
$181K2×2 trades
$926K2×2 trades
2025
$201K2×2 trades
$270K1×1 trade
2024
$1.38M14×14 trades
$175K2×2 trades
2023
$777K3×3 trades
$503K2×2 trades
2022
—
$285K2×2 trades
2020
$166K5×5 trades
$6.62M2×2 trades
2019
$25K1×1 trade
—
2018
$248K7×7 trades
$2.03M1×1 trade
2017
$386K2×2 trades
$5.46M3×3 trades
2016
$100K2×2 trades
$2.39M3×3 trades
2015
$91K1×1 trade
$1.35M1×1 trade
2014
$36K1×1 trade
$2.47M2×2 trades
2013
$811K16×16 trades
—
2012
$1.52M14×14 trades
—
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
From the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
When insiders usually buy
Last results
Oct 29, 2026
Within the 30 days after it, until Nov 28, 2026
Next results, expected
Feb 10, 2027
before the market opens; the date can move until the company confirms it
Purchases after results
60%
42 of 70 insider purchases since 2012 came within 30 days after a results announcement
From Healthcare Realty Trust's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Healthcare Realty Trust's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of Healthcare Realty Trust filed 2 open-market purchases (about $181K, in 2 filings, by 2 people) and 2 open-market sales (about $926K, in 2 filings, by 2 people). One Form 4 can list many transactions. In the 12 months before that, they filed 8 open-market purchases (about $693K, in 7 filings) and 3 open-market sales (about $445K, in 2 filings). (Healthcare Realty Trust on OQRO)
Funds and stakes. Fund 13F filings recorded in the 12 months show 9 new or larger positions and 7 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings. FINRA short interest for HR on the settlement date of Oct 30, 2026 was 16,960,080 shares (-3.01% on the previous report), about 2.63 days of average volume. In 13F filings for the quarter ended Jun 30, 2026, the largest positions that grew: Cohen & Steers, Inc. (increased, 814,918 shares); Capital Investment Advisors, LLC (increased, 28,847 shares); the largest that shrank: Robeco Institutional Asset Management B.V. (sold out); Oversea-Chinese Banking Corp Ltd (sold out). A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press. Healthcare Realty Trust filed a Form 8-K on Oct 29, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors. Healthcare Realty Trust filed a Form 8-K on Feb 23, 2026 (Item 4.01) that OQRO classes as: changed its auditor.
Who holds it. 457 funds reported a stake in Healthcare Realty Trust in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (15.1% of the value reported), COHEN & STEERS, INC. (14.1% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (7.7% of the value reported).
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. An 8-K item says what the company reported, not what it means for the share price.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of Healthcare Realty Trust filed 2 open-market purchases (about $181K, in 2 filings, by 2 people) and 2 open-market sales (about $926K, in 2 filings, by 2 people). One Form 4 can list many transactions.
In the 12 months before that, they filed 8 open-market purchases (about $693K, in 7 filings) and 3 open-market sales (about $445K, in 2 filings).
The largest purchase: Thomas N Bohjalian, Director, about $181K, filed Mar 6, 2026.
The largest sale: Amanda L Callaway, SVP & Chief Accounting Officer, about $525K, filed Jun 23, 2026.
Funds and stakes
Fund 13F filings recorded in the 12 months show 9 new or larger positions and 7 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Contracts, lobbying and filings
FINRA short interest for HR on the settlement date of Oct 30, 2026 was 16,960,080 shares (-3.01% on the previous report), about 2.63 days of average volume.
In 13F filings for the quarter ended Jun 30, 2026, the largest positions that grew: Cohen & Steers, Inc. (increased, 814,918 shares); Capital Investment Advisors, LLC (increased, 28,847 shares); the largest that shrank: Robeco Institutional Asset Management B.V. (sold out); Oversea-Chinese Banking Corp Ltd (sold out). A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press
Healthcare Realty Trust filed a Form 8-K on Oct 29, 2026 (Items 2.02, 7.01) that OQRO classes as: reported its results, and shared information with investors.
Healthcare Realty Trust filed a Form 8-K on Feb 23, 2026 (Item 4.01) that OQRO classes as: changed its auditor.
Latest results: quarter ending Sep 30, 2026
Revenue
$287M
−3.7% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
$4.23B
Debt $4.25B, cash $17.5M, at Sep 30, 2026
Net income, last 12 months
−$44.9M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 29, 2026.
The company's own opening sentence of that report reads: "On February 19, 2026, the Audit Committee of the Board of Directors (the 'Audit Committee') of Healthcare Realty Trust Incorporated (the 'Company'), elected to replace BDO USA, P.C. ("BDO") with Deloitte & Touche LLP ('Deloitte')..."
Healthcare Realty Trust filed a Form 8-K on Jan 7, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "Appointment of Executive Vice President and Chief Financial Officer The Board of Directors of Healthcare Realty Trust Incorporated (the 'Company') has appointed Daniel Gabbay to serve as the Company’s Executive Vice President and..."
Press coverage listed by Finnhub: "Healthcare Realty: This 5% Yielder Is Still Too Cheap To Ignore" (SeekingAlpha, Nov 9, 2026).
Press coverage listed by Finnhub: "Healthcare Realty Trust Q3 Earnings Call Highlights" (Yahoo, Oct 30, 2026).
HR closed at $19.36 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $17.24 to $19.36, a change of +12.3%.
Who holds it
457 funds reported a stake in Healthcare Realty Trust in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (15.1% of the value reported), COHEN & STEERS, INC. (14.1% of the value reported), VANGUARD PORTFOLIO MANAGEMENT LLC (7.7% of the value reported).
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
Fails to deliver: 67K shares (about $1.2M) were not delivered on time for settlement on Oct 27, 2026. SEC fails-to-deliver data.
Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 42.4% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (24.6% on ATS, 17.8% with other brokers), close to its 26-week average of 41.8%. Weeks of Oct 5 to Oct 30, 2026.
Week of May 4ATSOther off-exchangeFull height = all shares tradedWeek of Oct 26
Largest ATS: INTELLIGENT CROSS LLC (16.8%), BIDS ATS (11.6%), UBS ATS (10.4%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
2 certified in FY2026 Q3, vs 1 a year earlier. 2 positions in total, median offered wage $70K a year.
Staff Accountant · 1Staff Accountant II · 1
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Where the revenue comes from
Latest quarter
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Oct 29, 2026. Quarterly reports are not audited. Read the filing
By product or service
Management fee income/other$5.68M72%
+21% on the same quarter a year earlier ($4.71M)
Parking income$2.24M28%
+2.6% on the same quarter a year earlier ($2.18M)
Total revenue$7.92M+15%
The full fiscal year ended Dec 31, 2025
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 13, 2026. Read the filing
By product or service
Management fee income$19.6M70%
+100% on the year before ($9.83M)
Parking income$8.6M30%
−7.8% on the year before ($9.33M)
Total revenue$28.2M+47%
The year in the managers' words
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 13,000 words.
From “Overview”, in the company's words
The Company owns and operates properties that facilitate the delivery of healthcare services in primarily outpatient settings. To execute its strategy, the Company engages in a broad spectrum of integrated services including leasing, management, acquisition, financing, development and redevelopment of such properties. The Company seeks to generate stable, growing income and lower the long-term risk profile of its portfolio of properties by focusing on facilities primarily located on or near the campuses of acute care hospitals associated with leading health systems.
What the section covers (40 headings)
Risks relating to our business and operations
Risks relating to our capital structure and financings
Risks relating to government regulations
Overview
Liquidity and Capital Resources
Sources and Uses of Cash
Operating Activities
Investing Activities
Capital Funding
Real Estate Notes Receivable
Dispositions
Subsequent Dispositions
Financing Activities
Common Stock Repurchases
And 26 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 13, 2026 and Form 10-Q filed Oct 29, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Risk factors in the annual report
Latest annual report filed Feb 13, 2026, compared with the one filed Feb 19, 2025. Read the filing
All 42 risk factor headings match the year before, give or take wording.
Legal proceedings (Item 3)
The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company's consolidated financial position, results of operations, or cash flows.
Source: SEC EDGAR, Form 10-K filed Feb 13, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.